Pharsight

Drugs that contain Pralatrexate

1. Folotyn patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6028071 ACROTECH Purified compositions of 10-propargyl-10-deazaaminopterin and methods of using same in the treatment of tumors
Jul, 2022

(1 year, 8 months ago)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8299078 ACROTECH Treatment of T-cell lymphoma using 10-propargyl-10-deazaaminopterin
May, 2025

(1 year, 2 months from now)

US7622470 ACROTECH Treatment of T-cell lymphoma using 10-propargyl-10-deazaaminopterin
May, 2025

(1 year, 2 months from now)

Market Authorisation Date: 24 September, 2009

Treatment: Treatment of patients with relapsed or refractory peripheral t-cell lymphoma

Dosage: SOLUTION;INTRAVENOUS

How can I launch a generic of FOLOTYN before it's drug patent expiration?
More Information on Dosage

FOLOTYN family patents

Family Patents